Accumulation of the SET protein in HEK293T cells and mild oxidative stress: Cell survival or death signaling

Molecular and Cellular Biochemistry

Volumn 363, Issue 1-2, 2012, Pages 65-74

  Leopoldino, Andréia M ^a   Squarize, Cristiane H ^b   Garcia, Cristiana B ^a   Almeida, Luciana O ^a   Pestana, Cezar R ^a   Polizello, Ana C M ^a   Uyemura, Sérgio A ^a   Tajara, Eloiza H ^c   Gutkind, J Silvio ^d   Curti, Carlos ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

^c FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Akt phosphorylation; Cell death; I2PP2A; Oxidative stress; PTEN phosphorylation; SET

Indexed keywords

CASPASE; GLUTATHIONE; LIPOCORTIN 5; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN KINASE B; PROTEIN SET; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CYTOPLASM; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION;

APOPTOSIS; BLOTTING, WESTERN; CASPASES; CELL NUCLEUS; CELL SURVIVAL; CYTOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GLUTATHIONE; HEK293 CELLS; HISTONE CHAPERONES; HUMANS; OXIDANTS; OXIDATIVE STRESS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TERT-BUTYLHYDROPEROXIDE; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84857907352     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1158-x     Document Type: Article

References (51)

1. Franke TF, Kaplan DR, Cantley LC (1997) PI3K: downstream AKTion blocks apoptosis. Cell 88(4):435-437. doi:10.1016/S0092-8674(00)81883-8 (Pubitemid 27154408)
2. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW (1998) Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95(1):29-39. doi:10.1016/S0092-8674(00)81780-8 (Pubitemid 28458022)
3. Kuo YC, Huang KY, Yang CH, Yang YS, Lee WY, Chiang CW (2008) Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 283(4):1882-1892. doi:10.1074/jbc.M709585200
4. Li M, Damuni Z (1998) I1PP2A and I2PP2A. Two potent protein phosphatase 2A-specific inhibitor proteins. Methods Mol Biol 93:59-66
5. ten Klooster JP, Leeuwen I, Scheres N, Anthony EC, Hordijk PL (2007) Rac1-induced cell migration requires membrane recruitment of the nuclear oncogene SET. EMBO J 26(2):336-345. doi: 10.1038/sj.emboj.7601518 (Pubitemid 46160935)
6. Canela N, Rodriguez-Vilarrupla A, Estanyol JM, Diaz C, Pujol MJ, Agell N, Bachs O (2003) The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity. J Biol Chem 278(2):1158-1164. doi:10.1074/jbc.M207497200 (Pubitemid 36790797)
7. Fukukawa C, Shima H, Tanuma N, Okada T, Kato N, Adachi Y, Kikuchi K (2005) The oncoprotein I-2PP2A/SET negatively regulates the MEK/ERK pathway and cell proliferation. Int J Oncol 26(3):751-756
8. Zhao T, Zhang H, Guo Y, Zhang Q, Hua G, Lu H, Hou Q, Liu H, Fan Z (2007) Granzyme K cleaves the nucleosome assembly protein SET to induce single-stranded DNA nicks of target cells. Cell Death Differ 14(3):489-499. doi:10.1038/sj.cdd.4402040
9. Patel V, Hood BL, Molinolo AA, Lee NH, Conrads TP, Braisted JC, Krizman DB, Veenstra TD, Gutkind JS (2008) Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 14(4):1002-1014. doi:10.1158/1078-0432.CCR-07-1497 (Pubitemid 351302545)
10. Madeira A, Pommet JM, Prochiantz A, Allinquant B (2005) SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain. FASEB J 19(13):1905-1907. doi:10.1096/fj.05-3839fje (Pubitemid 41598790)
11. Constantinou C, Papas KA, Constantinou AI (2009) Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy? Curr Cancer Drug Targets 9(6):717-728
12. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674. doi:10.1016/j.cell.2011.02.013
13. Pani G, Galeotti T, Chiarugi P (2010) Metastasis: cancer cell's escape from oxidative stress. Cancer Metastasis Rev 29(2):351-378. doi:10.1007/s10555- 010-9225-4
14. Antico Arciuch VG, Galli S, Franco MC, Lam PY, Cadenas E, Carreras MC, Poderoso JJ (2009) Akt1 intramitochondrial cycling is a crucial step in the redox modulation of cell cycle progression. PLoS One 4(10):e7523. doi:10.1371/journal.pone.0007523
15. Chetram MA, Don-Salu-Hewage AS, Hinton CV (2011) ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells. Biochem Biophys Res Commun 410(2):195-200. doi:10.1016/j.bbrc.2011.05.074
16. Thomas P, Smart TG (2005) HEK293 cell line: a vehicle for the expression of recombinant proteins. J Pharmacol Toxicol Methods 51(3):187-200. doi:10.1016/j.vascn.2004.08.014 (Pubitemid 40615599)
17. Castilho RM, Squarize CH, Chodosh LA, Williams BO, Gutkind JS (2009) mTOR mediates Wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 5(3):279-289. doi: 10.1016/j.stem.2009.06.017
18. Yuan JS, Reed A, Chen F, Stewart CN Jr (2006) Statistical analysis of real-time PCR data. BMC Bioinformatics 7:85. doi: 10.1186/1471-2105-7-85
19. Zhu Y, Hoell P, Ahlemeyer B, Sure U, Bertalanffy H, Krieglstein J (2007) Implication of PTEN in production of reactive oxygen species and neuronal death in in vitro models of stroke and Parkinson's disease. Neurochem Int 50(3):507-516. doi: 10.1016/j.neuint.2006.10.010 (Pubitemid 46186601)
20. Franke TF, Kaplan DR, Cantley LC, Toker A (1997) Direct regulation of the Akt proto-oncogene product by phosphatidylinositol- 3,4-bisphosphate. Science 275(5300):665-668. doi: 10.1126/science.275.5300.665 (Pubitemid 27061333)
21. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7(2):97-110. doi:10.1016/j.drup. 2004.01.004 (Pubitemid 38736063)
22. Aliev G (2011) Oxidative stress induced-metabolic imbalance, mitochondrial failure, and cellular hypoperfusion as primary pathogenetic factors for the development of Alzheimer disease which can be used as a alternate and successful drug treatment strategy: past, present and future. CNS Neurol Disord Drug Targets 10(2):147-148
23. Harrison EM, Sharpe E, Bellamy CO, McNally SJ, Devey L, Garden OJ, Ross JA, Wigmore SJ (2008) Heat shock protein 90-binding agents protect renal cells from oxidative stress and reduce kidney ischemia-reperfusion injury. Am J Physiol Renal Physiol 295(2):F397-F405. doi:10.1152/ajprenal.00361.2007
24. Chohan MO, Khatoon S, Iqbal IG, Iqbal K (2006) Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine. FEBS Lett 580(16):3973-3979. doi: 10.1016/j.febslet.2006.06.021 (Pubitemid 43946883)
25. Carlson SG, Eng E, Kim EG, Perlman EJ, Copeland TD, Ballermann BJ (1998) Expression of SET, an inhibitor of protein phosphatase 2A, in renal development and Wilms' tumor. J Am Soc Nephrol 9(10):1873-1880 (Pubitemid 28443484)
26. Li M, Makkinje A, Damuni Z (1996) The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem 271(19):11059-11062. doi:10.1074/jbc.271.19.11059 (Pubitemid 26155931)
27. Tanimukai H, Grundke-Iqbal I, Iqbal K (2005) Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am J Pathol 166(6):1761-1771. doi:10.1016/S0002-9440(10)62486-8 (Pubitemid 40734399)
28. Chen H, Zhou L, Lin CY, Beattie MC, Liu J, Zirkin BR (2010) Effect of glutathione redox state on Leydig cell susceptibility to acute oxidative stress. Mol Cell Endocrinol 323(2):147-154. doi: 10.1016/j.mce.2010.02.034
29. Walsh B, Pearl A, Suchy S, Tartaglio J, Visco K, Phelan S (2009) Overexpression of Prdx6 and resistance to peroxide-induced death in Hepa1-6 cells: Prdx suppression increases apoptosis. Redox Rep 14(6):275-284. doi:10.1179/135100009X12525712409652
30. Skrzycki M, Majewska M, Podsiad M, Czeczot H (2009) Expression and activity of superoxide dismutase isoenzymes in colorectal cancer. Acta Biochim Pol 56(4):663-670
31. Welsh S, Bellamy W, Briehl M, Powis G (2002) The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res 62(17):5089-5095 (Pubitemid 34984438)
32. Azzu V, Jastroch M, Divakaruni A, Brand M (2010) The regulation and turnover of mitochondrial uncoupling proteins. Biochim Biophys Acta. doi:10.1016/j.bbabio.2010.02.035
33. Himms-Hagen J, Harper M (2001) Physiological role of UCP3 may be export of fatty acids from mitochondria when fatty acid oxidation predominates: an hypothesis. Exp Biol Med (Maywood) 226(2):78-84
34. Huppertz C, Fischer B, Kim Y, Kotani K, Vidal-Puig A, Slieker L, Sloop K, Lowell B, Kahn B (2001) Uncoupling protein 3 (UCP3) stimulates glucose uptake in muscle cells through a phosphoinositide 3-kinase-dependent mechanism. J Biol Chem 276(16):12520-12529. doi:10.1074/jbc.M011708200
35. Kim D, Oh B, Kim Y (2009) Splicing factor ASF/SF2 and transcription factor PPAR-gamma cooperate to directly regulate transcription of uncoupling protein-3. Biochem Biophys Res Commun 378(4):877-882. doi:10.1016/j.bbrc.2008. 12.009
36. Vazquez F, Ramaswamy S, Nakamura N, Sellers WR (2000) Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol 20(14):5010-5018 (Pubitemid 30431555)
37. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK (1998) The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 95(23):13513-13518. doi:10.1073/pnas.95.23.13513 (Pubitemid 28523003)
38. Song MS, Carracedo A, Salmena L, Song SJ, Egia A, Malumbres M, Pandolfi PP (2011) Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell 144(2):187-199. doi:10.1016/j.cell.2010.12. 020
39. Choi YC, Lee JH, Hong KW, Lee KS (2004) 17 Beta-estradiol prevents focal cerebral ischemic damages via activation of Akt and CREB in association with reduced PTEN phosphorylation in rats. Fundam Clin Pharmacol 18(5):547-557. doi:10.1111/j.1472-8206.2004.00284.x (Pubitemid 39468963)
40. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C (1995) A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 184(1):39-51. doi:10.1016/0022-1759(95)00072-I
41. Bröker LE, Kruyt FA, Giaccone G (2005) Cell death independent of caspases: a review. Clin Cancer Res 11(9):3155-3162. doi: 10.1158/1078-0432.CCR- 04-2223 (Pubitemid 40627860)
42. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC (1998) Regulation of cell death protease caspase-9 by phosphorylation. Science 282(5392):1318-1321. doi:10.1126/science.282.5392.1318 (Pubitemid 28524494)
43. Gao Y, Ordas R, Klein JD, Price SR (2008) Regulation of caspase- 3 activity by insulin in skeletal muscle cells involves both PI3-kinase and MEK-1/2. J Appl Physiol 105(6):1772-1778. doi: 10.1152/japplphysiol.90636.2008
44. Liu GP, Wei W, Zhou X, Zhang Y, Shi HH, Yin J, Yao XQ, Peng CX, Hu J, Wang Q, Li HL, Wang JZ (2010) I(2)(PP2A) regulates p53 and Akt correlatively and leads the neurons to abort apoptosis. Neurobiol Aging. doi:10.1016/j. neurobiolaging.2010.01.016
45. Bononi A, Agnoletto C, De Marchi E, Marchi S, Patergnani S, Bonora M, Giorgi C, Missiroli S, Poletti F, Rimessi A, Pinton P (2011) Protein kinases and phosphatases in the control of cell fate. Enzyme Res 2011:329098. doi:10.4061/2011/329098
46. Fan C, He L, Kapoor A, Rybak AP, De Melo J, Cutz JC, Tang D (2009) PTEN inhibits BMI1 function independently of its phosphatase activity. Mol Cancer 8:98. doi:10.1186/1476-4598-8-98
47. Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y (2007) Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128(1):157-170. doi:10.1016/j.cell.2006.11.042 (Pubitemid 46048887)
48. Robey RB, Hay N (2009) Is Akt the "Warburg kinase"? - Aktenergy metabolism interactions and oncogenesis. Semin Cancer Biol 19(1):25-31. doi:10.1016/j.semcancer.2008.11.010
49. Chung SH (2009) Aberrant phosphorylation in the pathogenesis of Alzheimer's disease. BMB Rep 42(8):467-474
50. Ming M, Feng L, Shea CR, Soltani K, Zhao B, Han W, Smart RC, Trempus CS, He YY (2011) PTEN positively regulates UVB-induced DNA damage repair. Cancer Res 71(15):5287-5295. doi: 10.1158/0008-5472.CAN-10-4614
51. Kodera Y, Isobe K, Yamauchi M, Kondoh K, Kimura N, Akiyama S, Itoh K, Nakashima I, Takagi H (1994) Expression of nm23 H-1 RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis. Cancer 73(2):259-265. doi:10.1007/BF00309953 (Pubitemid 24030599)